SCHEMBL23654041

SCHEMBL23654041

Cc1ccc(NC(=O)c2ccnc(C(C)(F)F)c2)cc1/C(N)=C/C1=C(N)OCC2COCCN12

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 20/20 0.53
BRAF P15056 19/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19016388 0.89 RAF1 (0.52) RAF1BRAF
SCHEMBL23654825 0.87 RAF1 (0.52) RAF1BRAF
SCHEMBL23654349 0.84 RAF1 (0.49) RAF1BRAF
SCHEMBL23654044 0.82 RAF1 (0.49) RAF1BRAF
SCHEMBL23654852 0.79 RAF1 (0.49) RAF1BRAF
SCHEMBL19015992 0.77 RAF1 (0.68) RAF1BRAF
SCHEMBL23654359 0.77 RAF1 (0.49) RAF1BRAF
SCHEMBL21249985 0.75 RAF1 (0.48) RAF1BRAF
SCHEMBL19016543 0.74 RAF1 (0.47) RAF1BRAF
SCHEMBL21249948 0.74 RAF1 (0.48) RAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390404-B1 TRICYCLIC COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS NOVARTIS AG (CH) 2021-07-21 EP disclosed